Fig. 1 · Structure

Documents & Downloads

Amiloride hydrochloride dihydrate

Cat. No. A11728 CAS 17440-83-4
Amiloride hydrochloride dihydrate is a potent epithelial sodium channel blocker and selective low threshold (T-type) calcium channel protein inhibitor (KD=30μM).

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Amiloride hydrochloride dihydrate Research Summary

This section summarizes 3 in vitro studies and 1 in vivo study of Amiloride hydrochloride dihydrate from 3 published references. In vitro models include LNCaP cells. In vivo models include homozygous Wfdc2 KO and KI pups.

Amiloride hydrochloride dihydrate In Vitro Studies

In LNCaP cells, 10µM Amiloride individually reduced cell viability by 63.2%. Treatment with 10µM Amiloride for 72 h also produced a slight decrease in early apoptosis. In human sperm undergoing a switch from pHo 6.5 to pHo 7.7 with human serum albumin at 3 mg/ml, comparison in the absence and presence of Amiloride showed that 500 μM completely prevented alkalization. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Amiloride and LNCaP cell viability

Cell-based study · LNCaP cells [1]

In LNCaP cells, 10µM Amiloride individually reduced cell viability by 63.2%.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell viabilitycell viability reduction of 63.2%[1]

Literature-Reported Treatment Conditions

Treatment concentration
10µM
Vehicle
100% DMSO
Reported limits
Not stated in the sentences used: route, schedule.
Methods and source locations

Compound reported in the paper: Amiloride

Evidence for Amiloride as the hydrochloride form reported in the paper, not the dihydrate, hydrochloride form supplied as A11728; no salt equivalence, dose conversion or lot validation.

Materials and methods > 3-[4,5-Dimethylthiazol-2yl]-2,5-diphenyl-tetrazolium bromide assay (S20); Materials and methods > Statistical analysis (S48); Results > Amiloride enhances the sensitivity of HSPC cells to lapatinib (S120, S121, S122); Fig. 5 legend (S198, S199)

cell viability: cell viability; comparator: DMSO — Results > Amiloride enhances the sensitivity of HSPC cells to lapatinib (S122); Fig. 5 legend (S199)

Amiloride and alkalization in human sperm

Cell-based study · human sperm [2]

Human sperm were examined during a switch from pHo 6.5 to pHo 7.7, with human serum albumin present at 3 mg/ml. Comparison in the absence and presence of Amiloride isolated its effect: 500 μM completely prevented alkalization.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Changes in pHi upon a switch from pHo 6.5 to pHo 7.7Reported result amiloride (500 μM) completely prevented alkalization[2]

Literature-Reported Treatment Conditions

Treatment concentration
500 μM
Method
continuous flow of perfusion
Co-treatment
Other interventions in this design: a switch from pHo 6.5 to pHo 7.7; human serum albumin (HSA) 3 mg/ml. Compound effect isolated by the comparison: absence and presence of amiloride.
Reported limits
Not stated in the sentences used: schedule, vehicle.
Methods and source locations

Compound reported in the paper: Amiloride

The paper names Amiloride without stating the salt or form; not verified as the dihydrate, hydrochloride form supplied as A11728. No dose conversion or lot validation.

Methods > Sperm preparation (S14); Methods > Solutions for electrophysiological and fluorometric recordings (S90); Methods > Fluorometry (S117); Methods > Analysis of fluorometric and electrophysiologic data (S149); Fig. 3 legend (S174, S175)

Changes in pHi upon a switch from pHo 6.5 to pHo 7.7: Changes in pHi upon a switch from pHo 6.5 to pHo 7.7; comparator: absence and presence of amiloride — Fig. 3 legend (S174, S175)

Amiloride and early apoptosis in LNCaP cells

Cell-based study · LNCaP cells [1]

In LNCaP cells treated with 10µM Amiloride for 72 h, early apoptosis showed a slight decrease.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
early apoptosisearly apoptosis -39.6%[1]

Literature-Reported Treatment Conditions

Treatment concentration
10µM
Exposure duration
72 h
Reported limits
Not stated in the sentences used: route, vehicle.
Methods and source locations

Compound reported in the paper: Amiloride

Evidence for Amiloride as the hydrochloride form reported in the paper, not the dihydrate, hydrochloride form supplied as A11728; no salt equivalence, dose conversion or lot validation.

Materials and methods > Flow cytometry for apoptosis (S26); Results > Low dose amiloride and lapatinib combine to induce apoptosis in HSPC cells (S155, S156); Fig. 7 legend (S243, S244)

early apoptosis: early apoptosis; comparator: 100% DMSO — Results > Low dose amiloride and lapatinib combine to induce apoptosis in HSPC cells (S156)

Amiloride hydrochloride dihydrate In Vivo Studies

Pregnant mice received Amiloride via drinking water starting from the onset of pregnancy. Homozygous Wfdc2 KO and KI pups born to treated females showed reduced respiratory failure and longer survival than pups from untreated females. [3]

Reduced respiratory failure and longer survival in pups

Animal study · homozygous Wfdc2 KO and KI pups [3]

Pregnant mice were administered 0.2 mg/kg/day of amiloride via drinking water starting from the onset of pregnancy. Homozygous Wfdc2 KO and KI pups born to amiloride-treated females showed reduced respiratory failure and longer survival than those from untreated females. Treated pups had a median survival of approximately 3 days, which was over six times longer than that of untreated pups.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Survival plotsurvival approximately 3 days[3]

Conditions shared by the study groups

Route
via drinking water
Treatment course
starting from the onset of pregnancy
Vehicle
drinking water
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Amiloride 0.2 mg/kg/daynon-treated micePregnant mice were administered 0.2 mg/kg/day of amiloride via drinking water starting from the onset of pregnancy. Homozygous Wfdc2 KO and KI pups born to amiloride-treated females showed reduced respiratory failure and longer survival than those from untreated females. Treated pups had a median survival of approximately 3 days, which was over six times longer than that of untreated pups.[3]
Amiloride 0.2 mg/kg/day
Model: homozygous Wfdc2 KO and KI pups
Methods and source locations

Compound reported in the paper: Amiloride

The paper names Amiloride without stating the salt or form; not verified as the dihydrate, hydrochloride form supplied as A11728. No dose conversion or lot validation.

Results > Amiloride rescues respiratory failure in Wfdc2-deficient mouse models (S160, S161, S176, S177)

Survival plot: Survival plot; comparator: non-treated mice — Results > Amiloride rescues respiratory failure in Wfdc2-deficient mouse models (S160, S161, S176, S177)

Amiloride 0.2 mg/kg/day · Results > Amiloride rescues respiratory failure in Wfdc2-deficient mouse models (S160, S176, S177)

Specifications

Manufacturer Adooq Bioscience
Actions Blocker
CAS Number 17440-83-4
Formula C6H8ClN7O.HCl.2H2O
Molecular Weight 302.12
SMILES
C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.O.O.Cl

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
Water 17 mg/mL (56.26 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Amiloride hydrochloride dihydrate Research References

  1. [1] Jathal MK, Mudryj M, Dall'Era MA, et al. Amiloride sensitizes prostate cancer cells to the reversible tyrosine kinase inhibitor lapatinib by modulating Erbb3 subcellular localization. Cell Mol Life Sci (2024). PMID: 39725713 DOI: 10.1007/s00018-024-05540-5 Source material
  2. [2] Grahn E, Kaufmann SV, Askarova M, et al. Control of intracellular pH and bicarbonate by CO2 diffusion into human sperm. Nat Commun (2023). PMID: 37669933 DOI: 10.1038/s41467-023-40855-0 Source material
  3. [3] Roh JW, Seo SK, Oh J, et al. Amiloride mitigates respiratory distress caused by WFDC2 deficiency via inhibiting the epithelial sodium channel. Nat Commun (2026). PMID: 42717213 DOI: 10.1038/s41467-026-76582-5 Source material

Added to your cart

View Cart Checkout
Loading...